Loading…

Qatar’s assisted home hemodialysis program: A beacon of hope for the vulnerable patient

In a bold departure from conventional healthcare paradigms, Qatar’s Assisted Home Hemodialysis (AHHD) national program stands as a testament to Hamad Medical Corporation’s unwavering commitment to excellence. This innovative care model is tailored to address the distinct challenges of hemodialysis p...

Full description

Saved in:
Bibliographic Details
Published in:Qatar medical journal 2024-11, Vol.2024 (3)
Main Authors: Hamad, Abdullah, Abdelhai, Mohamed Yahya, Elsherbiny, Mostafa, Abdelwahed, Ahamad, Tolba, Hoda, Chembolu, Sandhya, Yasin, Fadumo, Ibrahim, Rania, Joseph, Shajahan, Almuhanadi, Teha, Alkadi, Mohamad, Al Malki, Hassan
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In a bold departure from conventional healthcare paradigms, Qatar’s Assisted Home Hemodialysis (AHHD) national program stands as a testament to Hamad Medical Corporation’s unwavering commitment to excellence. This innovative care model is tailored to address the distinct challenges of hemodialysis patients, particularly the elderly, who require ambulance transport. It provides them with the convenience of at-home dialysis with the full support of dedicated nursing care. AHHD included 76 patients from July 2021 to December 2022. It has significantly improved patients’ quality of life, achieving an exceptional 99% satisfaction rate with an extremely low complication rate. It has also delivered tangible improvements in health outcomes, marked by a reduction in hospitalizations, decreased transmission of COVID-19, cost-effectiveness, alleviating strain on ambulance services, and reducing demand for dialysis slots and manpower. In conclusion, the clinical and financial success of the AHHD program positions it as a superior alternative to traditional in-center dialysis, particularly in its capacity to cater to the needs of the most complex and challenging patient populations.
ISSN:0253-8253
2227-0426
DOI:10.5339/qmj.2024.28